Quantification of Cerebral Blood Flow by Arterial Spin Labeling in Vasospasm in Subarachnoid Haemorrhage
ASL-HSA
1 other identifier
interventional
50
1 country
1
Brief Summary
A technique of MRI infusion -l'Arterial Spin Labeling-, non-invasive and non-irradiating, repeatable over time, appears promising in the field. This sequence allows for routine, generate perfusion maps relating to the entire brain volume
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 18, 2015
CompletedFirst Posted
Study publicly available on registry
September 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedSeptember 23, 2015
September 1, 2015
3 years
September 18, 2015
September 22, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
exploitation of raw images provided with the waning of the acquisition of the sequence ASL.
15 days
Study Arms (1)
Monitoring a subarachnoid hemorrhage
OTHERAny patient hospitalized at the University Hospital of Angers in neurosurgical intensive care unit for supervision by ASL and DTC a subarachnoid hemorrhage from all etiologies (excluding traumatic). An analysis of the three sessions MRI performed systematically within the first 14 days of the start of symptoms revealing the HSA will be
Interventions
An analysis of the three sessions MRI performed systematically within the first 14 days of the start of symptoms revealing the HSA will be
Eligibility Criteria
You may qualify if:
- Adults.
- Who have given their written consent.
- Affiliated to a social security system.
- Any patient hospitalized at the University Hospital of Angers in neurosurgical intensive care unit for supervision by ASL and DTC a subarachnoid hemorrhage from all etiologies (excluding traumatic).
You may not qualify if:
- Contraindications to MRI
- patient hospitalized at the University Hospital of Angers in surgical intensive care for monitoring a subarachnoid hemorrhage.
- patient hospitalized at the University Hospital of Angers for monitoring a subarachnoid hemorrhage traumatic.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Angers
Angers, 49933, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aram TER MINASSIAN, Physician
UH ANGERS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 18, 2015
First Posted
September 23, 2015
Study Start
December 1, 2014
Primary Completion
December 1, 2017
Study Completion
January 1, 2018
Last Updated
September 23, 2015
Record last verified: 2015-09